AIP and acromegaly: Most of the tumors exhibiting low AIP expression (with or without germline AIP mutations) were invasive [8, 9], and patients harboring those tumors have a poor response to the medical treatment with SSAs, the mainstay of the medical treatment of acromegaly [7].